In France, the CBD craze has given rise to a thriving industry, encompassing everything from oils and cosmetics to infusions, capsules, and gummies. However, this rapid growth has been accompanied by inconsistent quality and sometimes unclear regulations. Now, several French brands are focusing on transparency and rigorous controls to build trust. This is the case with Hexa3, which specializes in manufacturing CBD oils produced in France and subjected to rigorous testing.
A range of CBD oils designed in France
The company Hexa3 is showcasing a range ofCBD oil Made and packaged in France, using hemp extracts from European crops, the brand offers several formulas adapted to different uses and concentration levels. The oils contain between 10 % and 50 % of cannabidiol, allowing users to adjust the dose according to their needs and tolerance.
In France, the daily recommended intake for wellness purposes is set at 50 mg of CBD per day for food supplements. This "wellness" dosage is intended to support relaxation, sleep, or recovery without any pharmacological effect.
The products are formulated with natural extracts combined with a plant-based base, most often organic hemp oil or MCT oil derived from coconut, known to enhance cannabinoid absorption. Hexa3 offers Broad Spectrum versions, free of THC, and Full Spectrum versions, containing a trace amount of this compound but compliant with the legal limit of 0.3 % set by European regulations.
Some formulas combine CBD with other natural ingredients, such as melatonin to promote sleep, or plant extracts to enhance relaxation. These products are registered as food supplements, not as medicines. Each batch is laboratory-tested to ensure compliance with THC levels and oil purity standards.
Solutions dedicated to wellness professionals
The market's growth isn't limited to individuals. Many businesses—specialty stores, pharmacies, organic retailers, and e-commerce platforms—now want to offer their own CBD product lines. To meet this demand, Hexa3 has launched a website specifically for businesses, positioning the brand as a... CBD oil supplier reliable and structured.
This professional platform offers a variety of Broad Spectrum and Full Spectrum CBD oils, available in packaging suitable for resale. Products are sold in lots or packs, with tax-free pricing designed for distributors.
Hexa3 also offers a white-label service, allowing retailers to market the products under their own label while benefiting from the brand's manufacturing and quality control. The company states that its oils comply with French legislation on authorized hemp extracts and that they possess the necessary certificates of analysis for distribution.
A sector under regulatory supervision
CBD regulations in France have undergone several adjustments in recent years. Since 2022, the sale of cannabidiol products has been permitted provided the THC content does not exceed 0.3%. Producers must guarantee the compliance of their extracts and provide analyses certifying the absence of prohibited substances. This legal development has clarified the status of CBD, which is now considered a wellness supplement rather than a therapeutic product.
The legal framework remains strict, however: no medical claim can be made without scientific validation and authorization from health authorities. Reputable manufacturers, such as Hexa3, therefore focus on providing information without overpromising, emphasizing the quality of ingredients, manufacturing processes, and traceability. This rigor contributes to the credibility of a sector that is still young but undergoing standardization.
Between science and responsible consumption
From a scientific perspective, CBD is the subject of a growing number of studies. Researchers are exploring its influence on various biological systems, including the endocannabinoid system and its potential interactions with stress, pain, and sleep. While some data are promising, the scientific community emphasizes that most results pertain to preclinical models or limited trials. Therefore, cannabidiol cannot yet be considered a medicine, but it is generating increasing interest as a wellness molecule.
It is important to distinguish between wellness uses, where the dosage remains moderate (around 50 mg/day), and medically supervised therapeutic uses. For example, CBD-based medications such as Epidiolex are prescribed to treat certain forms of epilepsy, with daily dosages reaching up to 1200 mg, under strict medical supervision.
This distinction between medical and comfort uses is gradually shaping the market. Consumers primarily seek safe products with known composition and verifiable manufacturing processes. French companies focusing on transparency and compliance, like Hexa3, are helping to strengthen trust in a sector that, until recently, lacked clear benchmarks.
A market on the path to stabilization
The CBD sector in France now appears to be entering a phase of maturation. After a period of rapid growth, marked by a wide variety of offerings and sometimes a lack of clarity, the trend is now towards regulation and professionalization. Quality controls, organic certification, and product traceability are becoming essential criteria.
Brands like Hexa3 play a representative role: they embody the desire to anchor French CBD production in a sustainable approach that respects standards and is transparent for the consumer. CBD is no longer just a fad, but a structured sector where science, regulation, and industry are gradually seeking a balance.
English 
French